Connect with us

Hot world news

Timeline of virus vaccine deals reveals EU’s lag behind UK

Timeline of virus vaccine deals reveals EU's lag behind UK

ECONOMIC NEWS

Timeline of virus vaccine deals reveals EU’s lag behind UK

While Britain was quick and aggressive in negotiating vaccine deals early in the coronavirus pandemic, the European Union took a more cautious approach that is now hindering its efforts to fight the virusBy The Associated PressFebruary 7, 2021, 8:06 AM• 2 min readShare to FacebookShare to TwitterEmail this articleWhile Britain was quick and aggressive in negotiating vaccine deals early in the coronavirus pandemic, the European Union took a more cautious approach that is now hindering its efforts to fight the virus.Here’s a look at when key vaccine deals were first announced:OXFORD-ASTRAZENECABritain: May 25, 2020 for up to 100 million doses, announced by AstraZeneca CEO Pascal Soriot.EU: Aug. 27, for up to 400 million doses.——PFIZER-BIONTECHBritain: July 20, for 30 million doses.EU: Nov. 11, for up to 300 million doses.——SANOFI-GLAXOSMITHKLINEBritain: July 29, for 60 million doses.EU: Sept. 18, for up to 300 million doses.——JOHNSON & JOHNSONBritain: Aug. 14, for 30 million doses.EU: Oct. 8, for up to 400 million doses.——NOVAVAXBritain: Aug. 14, for 60 million doses.EU: No contract announced to date. On Dec. 17, concluded exploratory talks on up to 200 million doses.——VALNEVABritain: Sept. 14, agreement for up to 190 million doses; on Feb. 1, 2021, deal sealed for another 40 million.EU: No contract signed to date. On Jan. 12, 2021, concluded exploratory talks on up to 60 million doses.———MODERNABritain: Nov. 16, for 5 million doses; on Nov. 29, a contract for 2 million more.EU: Nov. 25, for up to 160 million doses.———CUREVACEU: Nov. 17, for up to 405 million doses.Britain: Feb. 5, 2021 for up to 50 million doses.


Source link

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in ECONOMIC NEWS

To Top
error: Content is protected !!